KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $95.6 million.

  • Opko Health's Accumulated Expenses fell 2215.12% to $95.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.6 million, marking a year-over-year decrease of 2215.12%. This contributed to the annual value of $118.4 million for FY2024, which is 3138.22% up from last year.
  • According to the latest figures from Q3 2025, Opko Health's Accumulated Expenses is $95.6 million, which was down 2215.12% from $90.6 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Accumulated Expenses ranged from a high of $213.1 million in Q1 2021 and a low of $88.8 million during Q1 2024
  • Its 5-year average for Accumulated Expenses is $124.4 million, with a median of $112.0 million in 2022.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first crashed by 4921.31% in 2022, then surged by 3295.3% in 2024.
  • Quarter analysis of 5 years shows Opko Health's Accumulated Expenses stood at $193.5 million in 2021, then crashed by 49.21% to $98.3 million in 2022, then decreased by 8.33% to $90.1 million in 2023, then surged by 31.38% to $118.4 million in 2024, then dropped by 19.22% to $95.6 million in 2025.
  • Its Accumulated Expenses stands at $95.6 million for Q3 2025, versus $90.6 million for Q2 2025 and $113.2 million for Q1 2025.